PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation

Seminars in Oncology · Published 2026-06-01 · DOI 10.1016/j.seminoncol.2026.152504

Authors (13)

Fausto Petrelli, Federica Motta, Samanta Bodrato, Agostina De Stefani, Lorenzo Dottorini, Francesca Trevisan, Lorenza Bruschieri, Valentina Riboldi, Andrea Esposito, Mario Mattiello, Ivano Vavassori, Antonio Manfredi, Silvia Seghezzi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Petrelli, F., Motta, F., Bodrato, S., et al. (2026). PSMA PET/CT staging in intermediate-risk prostate cancer: Toward risk-adapted implementation. Seminars in Oncology. https://doi.org/10.1016/j.seminoncol.2026.152504

Related articles

• Antibody treatments for digestive cancers: Past, present, and future · Seminars in Oncology · 2025 · Same journal
• Genetic and systems-level regulation of cancer metabolism: From metabolic reprogramming to AI-driven precision oncology · Seminars in Oncology · 2026 · Same journal
• Risk of intensive care unit admission after immune checkpoint inhibitor use in cancer · Seminars in Oncology · 2026 · Same journal
• The role of circular RNAs in driving cancer advancement in low-oxygen conditions · Seminars in Oncology · 2025 · Same journal
• A bibliometric analysis of research evolution on peritoneal metastasis in colorectal cancer (2000–2026): advances in molecular mechanisms and therapeutic strategies · Seminars in Oncology · 2026 · Same journal
• Immuno-oncology approaches to overcome T cell exhaustion in melanoma · Seminars in Oncology · 2025 · Same journal
• Artificial intelligence in gynecologic oncology: A cautionary look in the Indian context · Seminars in Oncology · 2025 · Same journal
• Prognostic significance and therapeutic potential of pyroptosis in gynecological malignancies · Seminars in Oncology · 2026 · Same journal
• Pregnancy during pembrolizumab therapy for triple-negative breast cancer with onset of congenital hypothyroidism: Case report, literature review, and caution for clinical practice · Seminars in Oncology · 2026 · Same journal
• Tumor tough, therapy smarter: Rethinking CAR-T for pancreatic cancer · Seminars in Oncology · 2025 · Same journal